Key points are not available for this paper at this time.
Our findings suggest that this 23% incidence of false-negative biopsies represents significant cancer. This relatively high incidence is important to consider in treatment modalities in which prostate biopsy may be performed to determine response to therapy.
Rabbani et al. (Wed,) studied this question.